John Ransom Analyst Performance

Managing Director, Director of Healthcare Research Alternate Site Healthcare Providers/Healthcare In at Raymond James Financial

John Ransom is a stock analyst at Raymond James Financial focused in the medical sector, covering 19 publicly traded companies. Over the past year, John Ransom has issued 9 stock ratings, including strong buy and buy recommendations. While full access to John Ransom's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights John Ransom's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 28 Last 10 Years
Buy Recommendations: 88.89% 24 Buy Ratings
Companies Covered: 19 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	29.6%	8 ratings
Buy	59.3%	16 ratings
Hold	7.4%	2 ratings
Sell	3.7%	1 ratings

Out of 27 total stock ratings issued by John Ransom at Raymond James Financial, the majority (59.3%) have been Buy recommendations, followed by 29.6% Strong Buy, 7.4% Hold, and 3.7% Sell.

Best & Worst Calls

Best Call
0000.0%
SIX
Mar 2020
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
CYH
Aug 2015
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NYSE	63.2% of companies on NYSE	12 companies
NASDAQ	36.8% of companies on NASDAQ	7 companies

John Ransom, an analyst at Raymond James Financial, currently covers 19 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 17 companies	89.5%
	Consumer Staples 1 company	5.3%
	Consumer Discretionary 1 company	5.3%

John Ransom of Raymond James Financial specializes in stock coverage within the Medical sector, with additional focus on Consumer Staples and Consumer Discretionary companies.

Coverage Industries

Industry	Percentage
MED - OUTP/HM CRE 4 companies	21.1%
MED - HOSPITALS 3 companies	15.8%
MED - HMO 2 companies	10.5%
MEDICAL INFO SYS 2 companies	10.5%
FUNERAL SVS&REL 1 company	5.3%
MED - DRUGS 1 company	5.3%
OFFICES & CLINICS OF MEDICAL DOCTORS 1 company	5.3%
MEDICAL SERVICES 1 company	5.3%
HEALTH SERVICES 1 company	5.3%
DATA PROCESSING & PREPARATION 1 company	5.3%
MISCELLANEOUS AMUSEMENT & RECREATION SERVICES 1 company	5.3%
GENERAL MEDICAL & SURGICAL HOSPITALS 1 company	5.3%

About John Ransom

John Ransom has more than 35 years of experience in healthcare finance. He spent co-founded the healthcare finance group at First Union (now Wells Fargo) in 1987 before joining Raymond James in 1996 as a healthcare services analyst. In addition to serving as managing director of the healthcare group and a member of the Raymond James benefit committee, Mr. Ransom covers a diverse array of sectors, including managed care, healthcare providers and tech-enabled healthcare solutions. He earned his bachelor’s degree from Presbyterian College and his MBA from the University of Georgia.

Follow on LinkedIn

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
ACHC Acadia Healthcare	8/14/2025	Reiterated Rating	$20.77	$26.00	Outperform
RDNT RadNet	8/13/2025	Reiterated Rating	$63.60	$75.00	Strong-Buy
AVAH Aveanna Healthcare	8/11/2025	Upgrade	$6.14	$9.00	Outperform
SCI Service Corporation International	8/4/2025	Reiterated Rating	$79.03	$90.00	Outperform
THC Tenet Healthcare	7/23/2025	Reiterated Rating	$158.26	$200.00	Outperform
GRDN Guardian Pharmacy Services	5/14/2025	Set Price Target	$24.62	$28.00	Outperform
UNH UnitedHealth Group	4/21/2025	Reiterated Rating	$434.34	$540.00	Strong-Buy
RDNT RadNet	3/5/2025	Upgrade	$51.83	$65.00	Strong-Buy
CI Cigna Group	1/31/2025	Reiterated Rating	$296.88	$360.00	Strong-Buy

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.